Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04922788
Recruitment Status : Recruiting
First Posted : June 11, 2021
Last Update Posted : June 11, 2021
Information provided by (Responsible Party):
Nanogen Pharmaceutical Biotechnology Joint Stock Company

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 7, 2022
Estimated Study Completion Date : August 7, 2022